AirNexis Therapeutics, Inc.

Venture-backed company · Stage unknown· Palo Alto, CAairnexis.com

Explore the future of inhaled therapy for COPD with AirNexis's innovative AN01 dry powder inhaler designed for ease of use.

Rounds on record
1
Latest round
Jan 9, 2026
Form D equity offering
Latest round size
$62.0M
Form D industry: Biotechnology
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

1 additional officer or director

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. Private equity
    observed

    Listed in the portfolio of SR One Capital Management, LP (seen on or before Sep 15, 2026).

    seen on or before Sep 15, 2026 · A later owner ends or changes the venture chapter: new decision makers, new lenders, returns for the investors on record.

    Factthe private equity graph (sponsor portfolio and deal records)For Investors, acquirers, lenders, service providersOwnership and outcomes →
  2. $62M
    sold on Form D

    Filed a Form D on 9 Jan 2026: $62M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactSEC Form DFor Investors, lenders, service providersFinancing history →
  3. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  4. 4 directors
    board

    4 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
2024sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

1 round
  1. Jan 9, 2026
    Form D equity offering · $62.0M (form d sold) · 13 investors
    Fact Form D · “AirNexis Therapeutics, Inc. filed Form D: $62,000,000 sold of $200,000,000, Biotechnology”

Who would invest

1 investor on record, then the firms most like them

Already invested

1 investor on record

Strong comparable investors

0 firms

Firms that backed two or more of the companies this company's own investors also back.

No firm backed two or more of the companies this company's investors back, so there is no comparable investor on record yet.

Broader fit

1 firm

Firms that co-invest repeatedly with this company's investors and dated a new company in the last 12 months.

  1. EQT
    • Backed 1 company this company's investors also back
    • Co-invested 4 times with 1 of this company's investors
    • 3 new companies dated in the last 12 months, latest Aug 11, 2026
    • 6 funds raising or deploying (newest vintage 2024)

Ownership and outcomes

1 on record, from the private equity graph and exit reports
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read

Credit relationships

none on record
No lender position matched to this company.

People

2 officers, 4 directors

Timeline

1 event
  1. Mar 9, 2026
    AirNexis Therapeutics, Inc. filed Form D: $62,000,000 sold of $200,000,000, Biotechnology
    Form D filed Fact Form D

Evidence

20 observations
Every observation on this company
  • Description: Oct 1, 2026 Fact
  • Entity type: Corporation Mar 9, 2026 Fact Form D
  • Form D industry group: Biotechnology Mar 9, 2026 Fact Form D
  • Amendment: false Mar 9, 2026 Fact Form D
  • Revenue range (Form D): Decline to Disclose Mar 9, 2026 Fact Form D
  • Incorporated: withinFiveYears Mar 9, 2026 Fact Form D
  • Investors named on site: 1 Oct 1, 2026 Fact
  • Jurisdiction: Delaware Mar 9, 2026 Fact Form D
  • Amount sold (Form D): $62.0M Mar 9, 2026 Fact Form D
  • Offering amount (Form D): $200M Mar 9, 2026 Fact Form D
  • Exemptions: 06b Mar 9, 2026 Fact Form D
  • First sale: 2026-01-09 Mar 9, 2026 Fact Form D
  • Investors (Form D): 13 Mar 9, 2026 Fact Form D
  • Minimum investment (Form D): 0 Mar 9, 2026 Fact Form D
  • Securities offered: equity Mar 9, 2026 Fact Form D
  • Office address: Mar 9, 2026 Fact Form D
  • Listed on portfolio page: Frazier Life Sciences Management, LP Oct 1, 2026 Fact Firm website
  • Website status: ok Oct 1, 2026 Fact
  • Site title: Oct 1, 2026 Fact
  • Year of incorporation: 2024 Mar 9, 2026 Fact Form D

Relationships across DFX

on 1 other DFX graph
Across the graphs

AirNexis Therapeutics, Inc. is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

1 dated event on the change ledger, latest event first
  • Form D filed
    2026-03-09source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.